Hikma Pharmaceuticals PLC (HKMPF)
24.50
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Hikma Pharmaceuticals Market Cap: 5.436B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 5.436B |
| May 03, 2024 | 5.436B |
| May 02, 2024 | 4.955B |
| May 01, 2024 | 4.955B |
| April 30, 2024 | 4.955B |
| April 29, 2024 | 4.955B |
| April 26, 2024 | 4.955B |
| April 25, 2024 | 4.955B |
| April 24, 2024 | 4.955B |
| April 23, 2024 | 4.955B |
| April 22, 2024 | 4.955B |
| April 19, 2024 | 4.955B |
| April 18, 2024 | 4.955B |
| April 17, 2024 | 4.955B |
| April 16, 2024 | 5.381B |
| April 15, 2024 | 5.381B |
| April 12, 2024 | 5.381B |
| April 11, 2024 | 5.381B |
| April 10, 2024 | 5.381B |
| April 09, 2024 | 5.381B |
| April 08, 2024 | 5.381B |
| April 05, 2024 | 5.381B |
| April 04, 2024 | 5.381B |
| April 03, 2024 | 5.381B |
| April 02, 2024 | 5.381B |
| Date | Value |
|---|---|
| April 01, 2024 | 5.381B |
| March 28, 2024 | 5.185B |
| March 27, 2024 | 5.185B |
| March 26, 2024 | 5.185B |
| March 25, 2024 | 5.185B |
| March 22, 2024 | 5.185B |
| March 21, 2024 | 5.185B |
| March 20, 2024 | 5.185B |
| March 19, 2024 | 5.185B |
| March 18, 2024 | 5.185B |
| March 15, 2024 | 5.185B |
| March 14, 2024 | 5.185B |
| March 13, 2024 | 5.185B |
| March 12, 2024 | 5.185B |
| March 11, 2024 | 5.185B |
| March 08, 2024 | 5.185B |
| March 07, 2024 | 5.185B |
| March 06, 2024 | 5.347B |
| March 05, 2024 | 5.396B |
| March 04, 2024 | 5.396B |
| March 01, 2024 | 5.396B |
| February 29, 2024 | 5.396B |
| February 28, 2024 | 5.859B |
| February 27, 2024 | 5.859B |
| February 26, 2024 | 5.859B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.030B
Minimum
Sep 23 2022
8.727B
Maximum
Aug 05 2021
5.987B
Average
5.925B
Median
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 278.91M |
| Biodexa Pharmaceuticals Plc | 4.867M |
| Verona Pharma PLC | 1.208B |
| NuCana PLC | 8.204M |
| Autolus Therapeutics PLC | 1.082B |
Market Cap Related Metrics
| PE Ratio | 28.82 |
| PS Ratio | 1.895 |
| Price to Book Value | 2.473 |
| Price to Free Cash Flow | 10.22 |
| Price | 24.50 |
| Earnings Yield | 3.47% |
| Operating PE Ratio | 9.020 |
| Normalized PE Ratio | 15.08 |